Highly Sensitized Patients: Miami Transplant Institute Experience.

CONCLUSIONS: In highly sensitized patients who received desensitization with IVIG, the addition of Rituximab to our standard IS (and/or IVIG and plasmapheresis as per the immunologic risk stratification model) resulted in higher cumulative patient and graft survival. PMID: 26281142 [PubMed - indexed for MEDLINE]
Source: Clinical Transplants - Category: Transplant Surgery Tags: Clin Transpl Source Type: research